M. Falqués

发表

Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial

E. Stockfleth, R. Dominicus, R. von Kiedrowski, 2016, Dermatology and Therapy.

Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study

J. Szepietowski, U. Mrowietz, P. Kerkhof, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial

B. Piraccini, U. Blume-Peytavi, F. Scarci, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Efficacy And Safety Of Aclidinium Bromide 400 µg BID Compared With Placebo And Tiotropium In Patients With Moderate To Severe COPD

H. Magnussen, C. Caracta, E. G. Gil, 2010, ATS 2010.

A randomized placebo controlled trial of AZD8999 (LAS190792) a novel dual acting bronchodilator in asthmatics

C. Astbury, T. Mant, Helena Pujol, 2017 .

Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks

M. Lebwohl, L. Iversen, M. Ohtsuki, 2019, The British journal of dermatology.

High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunteers

W. Sondermann, G. Kokolakis, M. Aparici, 2022, Dermatology and Therapy.

The Impact of Allodynia on the Efficacy of Almotriptan When Given Early in Migraine: Data From the “Act When Mild” Study

P. Goadsby, C. Vila, G. Zanchin, 2011, The International journal of neuroscience.

Meta-Analysis of the Efficacy of Ebastine 20 mg Compared to Loratadine 10 mg and Placebo in the Symptomatic Treatment of Seasonal Allergic Rhinitis

P. Ratner, F. Chuecos, M. Falqués, 2005, International Archives of Allergy and Immunology.

A multicentre, randomised, parallel‐group, double‐blind, vehicle‐controlled and open‐label, active‐controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis

A. Tosti, U. Blume-Peytavi, V. Tebbs, 2021, Mycoses.

Randomised clinical trials: linaclotide phase 3 studies in IBS‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints

W. Chey, M. Currie, S. Shiff, 2013, Alimentary pharmacology & therapeutics.

Use of reflectance confocal microscopy to evaluate 5‐fluorouracil 0.5%/salicylic acid 10% in the field‐directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double‐blind, vehicle‐controlled trial

U. Reinhold, M. Ulrich, E. Stockfleth, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) *

K. Reich, P. Foley, R. Warren, 2021, The British journal of dermatology.

Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD.

H. Magnussen, H. Watz, E. Garcia Gil, 2009, Respiratory medicine.

Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD.

H. Magnussen, C. Caracta, A. Kirsten, 2012, Chest.

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

P J Goadsby, P. Goadsby, H. Göbel, 2008, Cephalalgia : an international journal of headache.

Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland

A. Walker, M. Moya, Douglas C. A. Taylor, 2013, The European Journal of Health Economics.